The results of a new study confirms a team of highly trained physicians and scientists with impressive credentials wasted their time confirming that ivermectin doesn’t work when used in treating COVID-19 infections when they could have been working on something else.
In the abstract of their lengthy and detailed report, the researchers concluded that “In this double-blind, randomized, placebo-controlled platform trial including 1206 US adults with COVID-19 during February 2022 to July 2022, the median time to sustained recovery was 11 days in the ivermectin group and 11 days in the placebo group. In this largely vaccinated (84%) population, the posterior probability that ivermectin reduced symptom duration by more than 1 day was less than 0.1%… These findings do not support the use of ivermectin among outpatients with COVID-19.”
No less than 30 MDs, PhDs, RNs, MHSs, DPPs (whatever a DPP is, sounds fancy), and MPHs contributed to the study and signed the report on a trial that last from February 2022 to July 2022, starting right after another study finding the same result had already been published.